Binding of antidepressants to human brain receptors: focus on newer generation compounds

@article{Cusack2005BindingOA,
  title={Binding of antidepressants to human brain receptors: focus on newer generation compounds},
  author={Bernadette Cusack and Albert Nelson and Elliott Richelson},
  journal={Psychopharmacology},
  year={2005},
  volume={114},
  pages={559-565}
}
Using radioligand binding assays and postmortem normal human brain tissue, we obtained equilibrium dissociation constants (Kds) for 17 antidepressants and two of their metabolites at histamine H1, muscarinic, α1-adrenergic, α2-adrenergic, dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2 receptors. Several newer antidepressants were compared with older drugs. In addition, we studied some antimuscarinic, antiparkinson, antihistamine, and neuroleptic compounds at some of these receptors. For the… Expand
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test
TLDR
The results strongly suggest that activation of 5- HT2A receptors is critically involved in the anxiolytic activity of paroxetine, whereas the 5-HT2A and 5-ht2B receptors are involved inThe anti-punishment action of venlafaxine in the FPT. Expand
In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists
TLDR
A large number of varied clinical and chemical classes of drugs that are active in the central nervous system that display potent H1R inverse agonist activity are reported on. Expand
Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy
TLDR
Evaluated cell membranes show that CBD interacts with human 5-HT1A receptors of the hippocampus and temporal neocortex, and at low concentrations, the effect of CBD upon Gi/o protein activation is limited, however, at high concentrations, CBD acts as an inverse agonist of 5- HT1A receptor. Expand
Investigation of a role for noradrenaline in the neurochemical and behavioural effects of an established and putative target for antianxiety/antidepressant drugs: a microdialysis and behavioural study in rats and NK1 receptor knockout mice.
The precise neurochemical effects of antidepressants that underlie their efficacy remain unclear. Many antidepressants modulate noradrenaline transmission in vivo. However, the selective serotoninExpand
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
TLDR
Although no clear relationship exists between the clinical efficacy, plasma concentration of SSRIs, nor any threshold that defines toxic concentrations, therapeutic drug monitoring (TDM) may be useful in special populations, such as in elderly patients, poor metabolizers (PM) of sparteine or mephenytoin (CYP2C19), and patients with liver and kidney impairment. Expand
Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.
TLDR
The present status of the development of (11)C- or (18)F-labeled ligands as tools for imaging NET in brain with PET in support of neuropsychiatric clinical research and drug development is summarized. Expand
The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat α1B-adrenoceptors
TLDR
The differential affinities for these receptors indicate that the alpha(1)-adrenoceptor subtype which activation is most increased by the augmented noradrenaline availability resultant from the blockade of neuronal reuptake is thealpha(1B)-adRenoceptor. Expand
Dual inhibitory action of trazodone on dorsal raphe serotonergic neurons through 5-HT1A receptor partial agonism and α1-adrenoceptor antagonism
TLDR
Trazodone, at concentrations relevant to its clinical effects, exerts weak partial agonism at 5-HT1AARs and disfacilitation of firing through α1-adrenoceptor antagonism, which converge in inhibiting dorsal raphe serotonergic neuron activity. Expand
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
TLDR
This study examined 101 clinical drugs and laboratory compounds to build a comprehensive understanding of α1‐adrenoceptor subtype affinity and selectivity and concluded that the addition of α blockers for the management of hypertension or BPH in people already taking tricyclic antidepressants and certain antipsychotics may not be beneficial. Expand
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
TLDR
Data suggest that dextromethorphan exerts some of its antidepressant actions through σ1 receptors, which has been hypothesized to display rapid-acting antidepressant activity based on pharmacodynamic similarities to the N-methyl-D-aspartate receptor antagonist ketamine. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
TLDR
At the human brain histamines H1 receptor, antidepressants remained among the most potent histamine H1 antagonists known, although their affinities for human receptors were lower than those for animal receptors. Expand
Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.
Using radioligand binding techniques, we determined the equilibrium dissociation constants (KD's) for a series of neuroleptics at the dopamine (D-2), muscarinic, histamine H1, alpha 1- and alphaExpand
Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics.
TLDR
The affinity and selectivity of binding for sixteen antidepressants, two of their metabolites, and three antihistaminics (H1) at five different muscarinic receptor subtypes exist: m1, m2, m3, m4, and m5 are determined. Expand
Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro.
Using radioligand binding techniques and human frontal cortex, we determined the equilibrium dissociation constants (KDs) of 25 antidepressants at the serotonin S1 (probably the S1A subtype) andExpand
Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
TLDR
Clozapine's unusual efficacy in refractory schizophrenic patients and its low incidence of extrapyramidal side effects may be explained, but because most other atypical neuroleptics studied lacked high affinity and selectivity at muscarinic receptor subtypes, it is likely that other mechanisms are involved as well. Expand
Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro.
Using radioligand binding techniques and human frontal cortex, we determined the equilibrium dissociation constants (KDs) of 17 neuroleptics at the serotonin 5-HT1A and serotonin 5-HT2 receptors withExpand
Histamine H1 receptors in human brain labelled with [3H]Doxepin
TLDR
The distribution of histamine H1 receptors in human central nervous system did not correlate with the previously reported distributions in rat brain and guinea pig brain determined by [3H]doxepin binding. Expand
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
TLDR
Although none of the drugs was potent for [3H]dopamine uptake blockade, sertraline was the most potent (Ki = 260 nM). Expand
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT
TLDR
3H-PAT seems to be a useful ligand for studying the biochemical and pharmacological characteristics of presynaptic autoreceptors in selected regions of rat brain. Expand
Interactions of trazodone with serotonin neurons and receptors
TLDR
It is unlikely that the inhibition of uptake into serotonin neurons in vivo in the brains of mice and rats contributes to the clinical antidepressant effects of trazodone. Expand
...
1
2
3
...